Hiromi Kan

896 total citations
32 papers, 460 citations indexed

About

Hiromi Kan is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Hiromi Kan has authored 32 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 22 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Hiromi Kan's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (9 papers). Hiromi Kan is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (9 papers). Hiromi Kan collaborates with scholars based in Japan, United States and Italy. Hiromi Kan's co-authors include Kazuaki Chayama, Hiroshi Aikata, Michio Imamura, Masataka Tsuge, Hidenori Ochi, Hideyuki Hyogo, Akira Hiramatsu, Yoshiiku Kawakami, Nobuhiko Hiraga and Takayuki Fukuhara and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Hiromi Kan

31 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromi Kan Japan 16 317 273 88 77 52 32 460
Themistoklis Vassiliadis Greece 17 427 1.3× 371 1.4× 48 0.5× 117 1.5× 54 1.0× 28 657
Eiji Tanaka Japan 8 314 1.0× 240 0.9× 53 0.6× 76 1.0× 58 1.1× 10 431
Yuta Wakui Japan 13 276 0.9× 199 0.7× 47 0.5× 43 0.6× 88 1.7× 23 467
Lydia L. Barlow United States 8 311 1.0× 284 1.0× 40 0.5× 41 0.5× 78 1.5× 10 486
G. Dultz Germany 14 301 0.9× 299 1.1× 66 0.8× 83 1.1× 61 1.2× 45 519
Mahmoud Khattab Egypt 14 650 2.1× 623 2.3× 81 0.9× 44 0.6× 76 1.5× 35 812
Barbara Guerrera Italy 12 560 1.8× 557 2.0× 71 0.8× 41 0.5× 69 1.3× 19 754
Paloma Muñoz‐de‐Rueda Spain 6 533 1.7× 523 1.9× 84 1.0× 35 0.5× 57 1.1× 8 614
Christoph Antoni Germany 10 269 0.8× 240 0.9× 23 0.3× 71 0.9× 49 0.9× 32 405
Shinn‐Chern Chen Taiwan 17 672 2.1× 612 2.2× 148 1.7× 64 0.8× 80 1.5× 38 831

Countries citing papers authored by Hiromi Kan

Since Specialization
Citations

This map shows the geographic impact of Hiromi Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Kan more than expected).

Fields of papers citing papers by Hiromi Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Kan. The network helps show where Hiromi Kan may publish in the future.

Co-authorship network of co-authors of Hiromi Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Kan. A scholar is included among the top collaborators of Hiromi Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Kan. Hiromi Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshino, Shuji, Keigo Nakatani, Hiromi Kan, et al.. (2020). Bordetella pertussis is a common pathogen in infants hospitalized for acute lower respiratory tract infection during the winter season. Journal of Infection and Chemotherapy. 27(3). 497–502. 8 indexed citations
2.
Uchida, Takuro, Michio Imamura, Hiromi Kan, et al.. (2017). Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology. Journal of General Virology. 98(5). 1040–1047. 15 indexed citations
3.
Uchida, Takuro, Michio Imamura, C. Nelson Hayes, et al.. (2017). Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice. Antimicrobial Agents and Chemotherapy. 61(9). 17 indexed citations
4.
Morio, Reona, Hideyuki Hyogo, Masahiro Hatooka, et al.. (2016). The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease. Journal of Gastroenterology. 52(2). 253–262. 8 indexed citations
5.
Kan, Hiromi, Michio Imamura, Takuro Uchida, et al.. (2016). Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing. The Journal of Infectious Diseases. 214(11). 1687–1694. 8 indexed citations
6.
Imamura, Michio, Masataka Tsuge, Hiromi Kan, et al.. (2016). The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients. Journal of Gastroenterology. 52(3). 366–375. 11 indexed citations
7.
Tsuge, Masataka, Nobuhiko Hiraga, Takuro Uchida, et al.. (2016). Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection. Journal of Gastroenterology. 51(11). 1073–1080. 21 indexed citations
8.
Akamatsu, Sakura, C. Nelson Hayes, Hidenori Ochi, et al.. (2015). Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A. Journal of Hepatology. 63(3). 554–563. 19 indexed citations
9.
Uchida, Takuro, Nobuhiko Hiraga, Michio Imamura, et al.. (2015). Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice. Virus Research. 213. 62–68. 7 indexed citations
10.
Kawaoka, Tomokazu, Michio Imamura, Hiromi Kan, et al.. (2015). Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report. Transplantation Proceedings. 47(3). 809–814. 2 indexed citations
11.
Ochi, Hidenori, Eisuke Murakami, Takuro Uchida, et al.. (2015). Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay. PLoS ONE. 10(6). e0130022–e0130022. 25 indexed citations
12.
Murakami, Eisuke, Masataka Tsuge, Nobuhiko Hiraga, et al.. (2015). Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones. Journal of Infection. 72(1). 91–102. 15 indexed citations
13.
Kan, Hiromi, Tomokazu Kawaoka, Tomoki Kobayashi, et al.. (2014). A case of syndrome of inappropriate secretion of antidiuretic hormone following transarterial embolization with cisplatin.. PubMed. 111(9). 1805–10. 2 indexed citations
14.
Fukuhara, Takayuki, Hideyuki Hyogo, Hidenori Ochi, et al.. (2014). Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus.. PubMed. 61(130). 323–8. 48 indexed citations
15.
Kan, Hiromi, Yuki Kimura, Hideyuki Hyogo, et al.. (2014). Non‐invasive assessment of liver steatosis in non‐alcoholic fatty liver disease. Hepatology Research. 44(14). E420–7. 22 indexed citations
16.
Honda, Yohji, Yoshiiku Kawakami, Hiromi Kan, et al.. (2014). A second attack of cholestasis associated with erythropoietic protoporphyria was successfully treated by plasma exchange and blood transfusion. Clinical Journal of Gastroenterology. 7(4). 333–337. 7 indexed citations
17.
Kan, Hiromi, Sho‐ichi Yamagishi, Ayako Ojima, et al.. (2014). Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis. 29(6). 480–484. 28 indexed citations
18.
Miyaki, Daisuke, Hiroshi Aikata, Hiromi Kan, et al.. (2013). Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy. Journal of Gastroenterology and Hepatology. 28(12). 1834–1841. 17 indexed citations
19.
Naeshiro, Noriaki, Hiroshi Aikata, Hideaki Kakizawa, et al.. (2013). Long‐term outcome of patients with gastric varices treated by balloon‐occluded retrograde transvenous obliteration. Journal of Gastroenterology and Hepatology. 29(5). 1035–1042. 14 indexed citations
20.
Naeshiro, Noriaki, Hideaki Kakizawa, Hiroshi Aikata, et al.. (2013). Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long‐term outcomes in 14 patients. Hepatology Research. 44(7). 740–749. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026